A previous meta-analysis focusing on patients undergoing percutaneous coronary intervention (PCI) found that elevated Lp(a) levels were linked to higher risks of all-cause mortality (risk ratio (RR): 1.26), cardiovascular death (RR: 1.58), myocardial infarction (RR: 1.44), revascularization (RR: 1.38), and stroke (RR: 1.18) [26]. Here, LPA is linked to myocardial infarction.